Clinical Trial: FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647198) titled 'FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence' on June 02.

Brief Summary: The aim of this randomized controlled clinical trial is to evaluate the efficacy of green tea (EGCG) and vitamin D3 supplementation in preventing uterine fibroid recurrence following fibroid removal.

Study Start Date: Aug. 22

Study Type: INTERVENTIONAL

Condition: Uterine Fibroids (Leiomyoma)

Intervention: COMBINATION_PRODUCT: Vitamin D and Green Tea

EGCG and Vitamin D3 (300 mg, 2000 IU respectively, in tablets Each tablet will contain 150 mg EGCG, 1000 IU Vitamin D

OTHER: Placebo

The placebo has no medication and the participa...